July 7, 2016 / 11:32 PM / in a year

BRIEF-Medicure receives response letter from FDA on Aggrastat SNDA for new indication

July 7 (Reuters) - Medicure Inc

* Medicure receives response letter from FDA on aggrastat SNDA for new indication

* Received a complete response letter from U.S. Food and Drug Administration (FDA) for its supplemental new drug application

* FDA does not approve application in its present form Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below